Results 191 to 200 of about 25,950 (247)

Dynamic Nature of the p75 Neurotrophin Receptor in Response to Injury and Disease

Journal of Neuroimmune Pharmacology, 2014
R. Meeker, Kimberly S Williams
semanticscholar   +1 more source

Reversal of Cognitive Impairment in gp120 Transgenic Mice by the Removal of the p75 Neurotrophin Receptor. [PDF]

Front Cell Neurosci, 2019
Speidell A, Asuni GP, Avdoshina V, Scognamiglio S, Forcelli P, Mocchetti I.   +5 more
europepmc   +1 more source

La mort cel·lular en el desenvolupament del sistema nerviós [PDF]

, 1996
Boix Torras, Jacint, Calderó i Pardo, Jordi, Esquerda, Josep E., Ribera, Joan   +3 more
core  

The p75 neurotrophin receptor evades the endolysosomal route in neuronal cells, favouring multivesicular bodies specialised for exosomal release

Journal of Cell Science, 2014
C. Escudero, O. M. Lazo, C. Galleguillos, Jose I. Parraguez, M. A. Lopez-Verrilli, Carolina Cabeza, Luisa León, Uzma Saeed, C. Retamal, Alfonso González, M. Marzolo, B. Carter, F. Court, F. Bronfman   +13 more
semanticscholar   +1 more source

The spatiotemporal expression and mineralization regulation of p75 neurotrophin receptor in the early tooth development. [PDF]

Cell Prolif, 2019
Zhao M, Wen X, Li G, Ju Y, Wang Y, Zhou Z, Song J.   +6 more
europepmc   +1 more source

Role of p75 neurotrophin receptor in neuronal autophagy in intracerebral hemorrhage in rats through the mTOR signaling pathway.

Cell Cycle, 2020
Wang L, Tian M, Hao Y.
europepmc   +1 more source

The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration [PDF]

Lilia Alberghina, Anna Maria Colangelo, S Rossel, LH Hartwell, P Nurse, L Alberghina, H Kitano, P Nurse, L Alberghina, CB Tyson, I Rupes, KC Chen, L Alberghina, L Alberghina, F Chang, M Tyers, DI Jeoung, L Alberghina, L Alberghina, AW Murray, P Nash, M Barberis, M Barberis, M Peter, M Cheng, P Jorgensen, P Jorgensen, C Cipollina, M Bentele, KA Janes, H Naoki, AJ Pocklington, BA Yankner, PC Wong, DJ Selkoe, SA Lipton, SA Scott, SM Yatin, U Dirnagl, HF Bradford, M Ankarcrona, E Bonfoco, MP Mattson, AG Yakovlev, JJ Velier, CW Cotman, NA Tatton, C-K Wu, PJ Whitehouse, E Masliah, DJ Selkoe, PJ Nestor, LF Lue, DB Freir, DM Walsh, CE Van der Zee, KS Chen, F Ruberti, B Connor, DT Loo, A Tortosa, E Masliah, PN Pompl, JH Su, S Cavallaro, PH Reddy, CJ Pike, TT Rohn, EC Yuen, RW Oppenheim, R Levi-Montalcini, R Levi-Montalcini, EJ Huang, MV Sofroniew, WC Mobley, TH Large, Y Li, M Goedert, SR Whittemore, W Fisher, LF Kromer, VE Koliatsos, MH Tuszynski, JD Cooper, MV Sofroniew, S Capsoni, R De Rosa, ES Levine, RM Holsinger, S Peng, M Fahnestock, AW Harrington, ME Reynolds, JD Oh, MS Beattie, EJ Mufson, SE Counts, MV Chao, R Lee, MV Chao, HK Teng, A Nykjaer, P Sarret, MD Ledesma, NH Woo, ME Eriksdotter Jonhagen, MH Tuszynski, I Mocchetti, W Froestl, S Roβner, RG Perez, D Scheuner, PF Chapman, L Tong, CS McCauslin, L Tong, RJ Rylett, S Roβner, C Costantini, RM Nitsch, S Roβner, RS Jope, JF Kelly, WA Pedersen, SL Chan, EM Snyder, U Wagner, C Barbato, JJ Pei, RV Bhat, JA Nicoll, C Hock, C Raoul, DW Ethell, Z Nagy, T Arendt, Y Yang, HM Beere, M Deshmukh, GV Putcha, ZZ Chong, HY Chang, SL Chan, GV Putcha, HL Li, X Luo, N Plesnila, C Culmsee, MV Chao, K Ryungsa, MH Cardone, A Brunet, A Caricasole, RS Aloyz, WW Smith, JL Garrido, PW Mesner, WJ Friedman, P Casaccia-Bonnefil, AH Salehi, G Khursigara, G Khursigara, RT Dobrowsky, AW Harrington, H Zhou, BA Stoica, BD Carter, M Hamanoue, T Yamashita, CJ Pike, RA Cherny, CM Troy, S Rabizadeh, M Yaar, C Costantini, M Yao, JJ Pei, Y Hashimoto, JW Lustbader, CM Troy, H Guo, G Cantarella, B Kaltschmidt, DW Choi, P Vanhoutte, MA De Bernardi, DE Wood, E Adamec, M-S Lee, GN Patrick, R Sadoul, N Canu, YA Lam, H Jick, L Puglielli, MP Mattson, MA Castro-Alamancos, LA Blair, E Carro, S Dore, M Shaw, WH Zheng, L Aloe, B Cheng, O Tetsu, K Herrup, A Copani, DS Park, DS Park, G Zeng, A McShea, U Ueberham, G Frasca, HJ Luth, A Giovanni, Y Chen, DL McPhie, L Zhao, PL McGeer, AJ Bruce-Keller, J Rogers, J Rogers, S Weggen, A Bachis, DP Martin, A Suzuki, B Eymin, MV Blagosklonny, J Hardy, L Alberghina, U Ueberham   +230 more
core   +1 more source

Some of the next articles are maybe not open access.

Related searches:

P75 neurotrophin receptor as a therapeutic target for drug development to treat neurological diseases

European Journal of Neuroscience, 2022
The interaction of neurotrophins with their receptors is involved in the pathogenesis and progression of various neurological diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, spinal cord injury and acute and ...
L. Xiong, Li Chen, I. Deng, Xin-Fu Zhou, Tinghua Wang   +4 more
semanticscholar   +1 more source

Is there a role for the p75 neurotrophin receptor in mediating degeneration during oxidative stress and after hypoxia?

Journal of Neurochemistry, 2021
Cholinergic basal forebrain (cBF) neurons are particularly vulnerable to degeneration following trauma and in neurodegenerative conditions. One reason for this is their characteristic expression of the p75 neurotrophin receptor (p75NTR), which is up ...
Kornraviya Sankorrakul, Lei Qian, W. Thangnipon, E. Coulson   +3 more
semanticscholar   +1 more source

Structural Characterization of the p75 Neurotrophin Receptor: A Stranger in the TNFR Superfamily.

Vitamins and hormones, 2017
M. Vilar
semanticscholar   +2 more sources